WaferGen Bio-systems, Inc.

Investor Relations

Investors

Email Alerts

Be among the first to receive latest Wafergen news, updates and events!

Company Information

WaferGen Bio-systems, Inc. is a biotechnology company that offers innovative genomic technology solutions for single-cell analysis and clinical research. The ICELL8™ Single-Cell  System is a revolutionary platform which can isolate thousands of single cells and processes specific cells for analysis, including Next Generation Sequencing. The system has demonstrated unbiased isolation of up to 1,800 single cells ranging from 5-100 µm in size on a single chip, including single cells from solid tumors, brain cells, pulmonary airway cells, and multiple cell lines. The SmartChip platform can be used for profiling and validating molecular biomarkers, and can perform massively-parallel single-plex PCR for one-step target enrichment and library preparation for clinical NGS. These technologies offer a powerful set of tools for biological analysis at the molecular and single-cell level in the life sciences, pharmaceutical, and clinical laboratory industries.

 

View Profile

Leadership

Rolland Carlson

President, Chief Executive Officer and Director

Dr. Carlson has substantial leadership experience from startup to full P&L line management, sales and marketing, business and new product development, distribution management, and international operations.  Prior to joining…

View Full Bio

Michael P. Henighan

Chief Financial Officer

Michael P. Henighan joined WaferGen in August 2014 as Chief Financial Officer. Prior to joining Wafergen, Michael was a founder and Chief Financial Officer of Aplegen, Inc. from February 2011 through August 2015. Prior to joining Aplegen…

View Full Bio

Maithreyan Srinivasan, Ph.D.

Chief Technology Officer

Maithreyan Srinivasan (Srini) joined WaferGen in January 2014 as a technology consultant and was promoted to Chief Technology Officer in May 2014. Earlier in his career, Srini worked for CuraGen and Roche 454 in a series of R&D roles of…

View Full Bio

Syed Husain

Senior Vice President, Engineering

Syed joined WaferGen in October 2009 with more than 20 years of experience in leading engineering teams and developing successful products and product lines in the life sciences and semiconductor industries. As vice president of…

View Full Bio

Jude Dunne, Ph.D.

Vice President, Product Development

Jude Dunne, Ph.D., joined WaferGen in July 2010 and has over 16 years of experience in product development spanning multiple roles and industries. In his role as Vice President, Jude has expanded responsibility in overseeing the…

View Full Bio

Andy Moye

Vice President, Sales

Andy Moye joined WaferGen in May 2015 and has 18 years of sales, operations, and business development experience. Prior to joining WaferGen, Andy was the Vice-President of Sales, Business Development, and Strategy at CombiMatrix, a…

View Full Bio

Yong Yi

Vice President, Marketing

Yong Yi has over 15 years of experience in the life sciences industry, including key leadership roles in marketing, application support, and R&D. Prior to joining Wafergen in May 2015, Yong was the Marketing Director at Agilent…

View Full Bio

Ivan Trifunovich, Ph.D.

Executive Chairman

Ivan Trifunovich, Ph.D., is an established leader in the healthcare and life science industries, where he has held a number of executive positions and served as a strategic consultant to global multi-national companies. He was the…

View Full Bio

Rolland Carlson

President, Chief Executive Officer and Director

Dr. Carlson has substantial leadership experience from startup to full P&L line management, sales and marketing, business and new product development, distribution management, and international operations.  Prior to joining…

View Full Bio

Joel Kanter

Lead Independent Director

Joel Kanter has been in the financial services industry for over three decades and has focused on providing equity and bridge financing to small- and mid-sized companies, and institutional financing to mature enterprises. He has served as…

View Full Bio

R. Dean Hautamaki, M.D.

Director

Dr. Hautamaki has served as our director since the closing of the Merger. Dr. Hautamaki is a practicing physician and since January 2005 has been the Assistant Clinical Professor of Medicine at the Florida State University College of…

View Full Bio

Makoto Kaneshiro

Director

Mr. Kaneshiro has served as director of WaferGen since March 2005. Mr. Kaneshiro is a founding member of Genetic Devices, Co., Ltd. in Japan and prior to that was the Executive Director of Overseas Investment for CSK Venture Capital Co.,…

View Full Bio

Robert Schueren

Director

Robert Schueren has held leadership positions in life science and diagnostic companies for more than two decades. Since April 2013, Mr. Schueren has been the Chief Executive Officer of IntegenX and a member of its Board of Directors.…

View Full Bio

William McKenzie

Director

William McKenzie has over 25 years of experience building new businesses in the global life sciences and diagnostics sectors. Most recently, Mr. McKenzie served as Vice President and General Manager of Molecular Diagnostics at PerkinElmer,…

View Full Bio

Arul M. Chinnaiyan, M.D., Ph.D.

Dr. Arul Chinnaiyan is a recognized leader in the use of biomarkers in the clinic to choose appropriate therapies for cancer patients. Biomarkers are characteristics that are measured and evaluated as an indicator of normal biologic…

View Full Bio

Muneesh Tewari, M.D., Ph.D.

Dr. Muneesh Tewari is a faculty member at Fred Hutchinson Cancer Research Center where he has focused on studying the role of microRNAs in cancer, as well as on developing microRNA-based biomarker approaches for oncology applications. Dr.…

View Full Bio

Paul R. Schimmel, Ph.D.

Dr. Paul Schimmel is currently at the Scripps Research Institute in San Diego serving as the Ernest and Jean Hahn Professor of Molecular Biology and Chemistry. Dr. Schimmel specializes in researching the mechanism of action of proteins and…

View Full Bio

David Gelfand, Ph.D.

Dr. David Gelfand joined WaferGen in 2007 as Chief Scientific Officer. Between October 2005 and August 2006, Dr. Gelfand worked as a consultant in the fields of molecular diagnostics, nucleic acid amplification, DNA sequencing and…

View Full Bio

Timothy J. Triche, M.D., Ph.D.

As Director of the Center for Personalized Medicine at Children’s Hospital Los Angeles, Dr. Timothy Triche manages a large cancer genomics, biology and nanotechnology laboratory research program funded by grants from the National…

View Full Bio